Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

13.43
-0.0700-0.52%
Post-market: 13.430.00000.00%19:56 EDT
Volume:2.23M
Turnover:29.57M
Market Cap:1.60B
PE:-12.91
High:13.55
Open:13.03
Low:12.72
Close:13.50
Loading ...
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Major Issues Report

8-K - Current report
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 15, 2021

Major Issues Report

8-K - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 29, 2020

Correspondence

CORRESP [Cover] - Correspondence
Sep 29, 2020

Correspondence

CORRESP [Cover] - Correspondence
Sep 29, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Major Issues Report

8-K - Current report
Sep 09, 2020

Major Issues Report

8-K - Current report